As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

Compared to the last administration, it’s like the dark of night and the light of day,” Alexandria Real Estate's founder said ...

A district court in New Jersey ruled that the plaintiff lacked standing for certain claims, but there is a chance the case ...